<div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <p>AnaCardio raises $62.5M Series A+ led by undisclosed investors.</p><p>Additional participants in this funding round include various venture capital firms.</p><p>AnaCardio develops new therapies for heart failure. The company is led by CEO unknown.</p><table class="vc-deal-terms"><tbody><tr><th>Company</th><td>AnaCardio</td></tr><tr><th>Round</th><td>Series A+</td></tr><tr><th>Amount</th><td>$62.5M</td></tr><tr><th>Sectors</th><td>biopharmaceutical</td></tr></tbody></table>
</div>


<div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <p>AnaCardio raises <strong>$62.5M</strong> Series A+ led by undisclosed investors.</p>
<p>Additional participants in this funding round include various <a href="/company/venture/">venture</a> capital firms.</p>
<p>AnaCardio develops new therapies for heart failure. The company is led by CEO unknown.</p>
<table class="vc-deal-terms"><tbody>
<tr>
<th>Company</th>
<td>AnaCardio</td>
</tr>
<tr>
<th>Round</th>
<td>Series A+</td>
</tr>
<tr>
<th>Amount</th>
<td><strong>$62.5M</strong></td>
</tr>
<tr>
<th>Sectors</th>
<td>biopharmaceutical</td>
</tr>
</tbody></table>
</div>


Anacardio Raises $62.5M Series A+

Anacardio Raises $62.5M Series A+ | Traded VC

ABOUT THIS STORY

<div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <p>AnaCardio raises <strong>$62.5M</strong> Series A+ led by undisclosed investors.</p>
<p>Additional participants in this funding round include various <a href="/company/venture/">venture</a> capital firms.</p>
<p>AnaCardio develops new therapies for heart failure. The company is led by CEO unknown.</p>
<table class="vc-deal-terms"><tbody>
<tr>
<th>Company</th>
<td>AnaCardio</td>
</tr>
<tr>
<th>Round</th>
<td>Series A+</td>
</tr>
<tr>
<th>Amount</th>
<td><strong>$62.5M</strong></td>
</tr>
<tr>
<th>Sectors</th>
<td>biopharmaceutical</td>
</tr>
</tbody></table>
</div>

Anacardio Raises $62.5M Series A+

ABOUT THIS STORY

Mach9 Raises $34M Series A+ Led by First Round Capital

Blacksmith Raises $66M at $1B Valuation

Vectorial Raises $3M From Industry Leaders

Company	AnaCardio
Round	Series A+
Amount	$62.5M
Sectors	biopharmaceutical

Anacardio Raises $62.5M Series A+

ABOUT THIS STORY

More articles

Mach9 Raises $34M Series A+ Led by First Round Capital

Blacksmith Raises $66M at $1B Valuation

Vectorial Raises $3M From Industry Leaders